Log In
person
iBio Inc
IBIO
summarize
2 total product lines
calendar_month
Revenue as of 06/30/2021
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biopharmaceuticals |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
1.1M | 46.29% |
| Bioprocessing |
Reagents, Chemicals and Proteins for Drug Manufacturers
These companies manufacture reagents, chemicals, and proteins that are used primarily used by drug manufacturers (pharma and biotech) and sell directly to their customers.
|
1.27M | 53.71% |
| keyboard_arrow_down |
Biopharmaceuticals
Pre-Revenue Pharmaceuticals
|
1.1M | 46.29% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||
| keyboard_arrow_down |
Bioprocessing
Reagents, Chemicals and Proteins for Drug Manufacturers
|
1.27M | 53.71% |
| keyboard_arrow_right |
These companies manufacture reagents, chemicals, and proteins that are used primarily used by drug manufacturers (pharma and biotech) and sell directly to their customers.
|
||